Taylor, Cottrill, Erickson & Associates, Inc. Icad Inc Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$338 Million
Q2 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 25, 2019	SELL	$5.62 - $7.86 $61,297 - $85,729	-10,907 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$3.65 - $6.05 $10,950 - $18,150	-3,000 Reduced 21.57%	10,907 $56,000
Q3 2018 Oct 24, 2018	SELL	$2.85 - $3.19 $19,950 - $22,330	-7,000 Reduced 33.48%	13,907 $40,000
Q1 2018 Apr 23, 2018	BUY	$2.96 - $4.0 $8,880 - $12,000	3,000 Added 16.75%	20,907 $64,000
Q3 2017 Oct 19, 2017	BUY	$3.3 - $4.42 $59,093 - $79,148	17,907	17,907 $79,000

Others Institutions Holding ICAD

# of Institutions

Shares Held

5.92M

Call Options Held

1.5K

Put Options Held

20.4K

Vanguard Group Inc Valley Forge, PA

1.13M
Shares

$1.73 Million
0.0% of portfolio
First Eagle Investment Management, LLC

702K
Shares

$1.07 Million
0.0% of portfolio
Portolan Capital Management, LLC Boston, MA

653K
Shares

$999,659
0.08% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

486K
Shares

$743,870
0.0% of portfolio
Black Rock Inc. New York, NY

350K
Shares

$535,458
0.0% of portfolio

View Full List

About ICAD INC

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $38.8M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

More about ICAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account